E2F1 promotes tumor cell invasion and migration through regulating CD147 in prostate cancer

  • Authors:
    • Yu-Xiang Liang
    • Jian-Ming Lu
    • Ru-Jun Mo
    • Hui-Chan He
    • Jian Xie
    • Fu-Neng Jiang
    • Zhuo-Yuan Lin
    • Yan-Ru Chen
    • Yong-Ding Wu
    • Hong-Wei Luo
    • Zheng Luo
    • Wei-De Zhong
  • View Affiliations

  • Published online on: January 29, 2016     https://doi.org/10.3892/ijo.2016.3364
  • Pages: 1650-1658
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Increased expression of E2F1 has been reported to be associated with tumor growth and cell survival of prostate cancer (PCa). However, its roles and mechanisms on PCa have not been fully elucidated. The present study found that E2F1 overexpression in PCa tissues was significantly associated with high Gleason score (P=0.01) and advanced pathological stage (P=0.02). In addition, PCa patients with high E2F1 expression more frequently had shorter biochemical recurrence-free survival (P=0.047) than those with low E2F1 expression. Then, we confirmed that the knock-down of E2F1 expression was able to inhibit cell cycle progression, invasion and migration of PCa cell lines in vitro, along with tumor xenograft growth and epithelial-to-mesenchymal transition (EMT) in vivo. Moreover, we identified CD147 as a novel interaction partner for E2F1 through bio-informatic binding site prediction, combined with chromatin immunoprecipitation-PCR (ChIP-PCR) and western blot analysis. Taken together, our data delineate an as yet unrecognized function of E2F1 as enhancer of tumor invasion and migration of PCa via regulating the expression of CD147 in PCa. Importantly, E2F1 may function as a biomarker that can differentiate patients with biochemical recurrent and non-biochemical recurrent disease following radical prostatectomy, highlighting its potential as a therapeutic target.
View Figures
View References

Related Articles

Journal Cover

April 2016
Volume 48 Issue 4

Print ISSN: 1019-6439
Online ISSN:1791-2423

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Liang, Y., Lu, J., Mo, R., He, H., Xie, J., Jiang, F. ... Zhong, W. (2016). E2F1 promotes tumor cell invasion and migration through regulating CD147 in prostate cancer. International Journal of Oncology, 48, 1650-1658. https://doi.org/10.3892/ijo.2016.3364
MLA
Liang, Y., Lu, J., Mo, R., He, H., Xie, J., Jiang, F., Lin, Z., Chen, Y., Wu, Y., Luo, H., Luo, Z., Zhong, W."E2F1 promotes tumor cell invasion and migration through regulating CD147 in prostate cancer". International Journal of Oncology 48.4 (2016): 1650-1658.
Chicago
Liang, Y., Lu, J., Mo, R., He, H., Xie, J., Jiang, F., Lin, Z., Chen, Y., Wu, Y., Luo, H., Luo, Z., Zhong, W."E2F1 promotes tumor cell invasion and migration through regulating CD147 in prostate cancer". International Journal of Oncology 48, no. 4 (2016): 1650-1658. https://doi.org/10.3892/ijo.2016.3364